Invention Grant
- Patent Title: N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
-
Application No.: US15445381Application Date: 2017-02-28
-
Publication No.: US09907855B2Publication Date: 2018-03-06
- Inventor: Jennifer Riggs-Sauthier , Wen Zhang
- Applicant: Nektar Therapeutics
- Applicant Address: US CA San Francisco
- Assignee: Nektar Therapeutics
- Current Assignee: Nektar Therapeutics
- Current Assignee Address: US CA San Francisco
- Agent Susan T. Evans
- Main IPC: C07C233/11
- IPC: C07C233/11 ; C07C235/26 ; C07C235/30 ; C07C235/32 ; A61K47/48 ; C07D235/22 ; A61K47/60
Abstract:
The invention relates to (among other things) N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides and compositions comprising the same. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
Public/Granted literature
- US20170165372A1 N-OPTIONALLY SUBSTITUTED ARYL-2-OLIGOMER-3-ALKOXYPROPIONAMIDES Public/Granted day:2017-06-15
Information query
